Celltrion Invests In UK’s Iksuda

Takes Controlling Stake In ADC Specialist Through $47m Financing Round

 
• By Dave Wallace

Celltrion has taken a controlling stake in ADC specialist Iksuda as part of a $47m financing round that has just been closed by the UK-based company.

Investment Money Hands Plant Grow
Celltrion has invested in ADC specialist Iksuda • Source: Alamy

Celltrion says it has become the largest shareholder of UK-based antibody drug conjugates developer Iksuda by participating alongside Mirae Asset Capital and Premier Partners in a $47m financing round that has just closed.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business